NxStage to Present at the Canaccord Genuity 32nd Annual Growth Conference

_{//health-fitness.news-articles.net/content/2012/ .. ccord-genuity-32nd-annual-growth-conference.html}
^{Published in Health and Fitness on Friday, August 10th 2012 at 5:15 GMT by Market Wire}  

NxStage to Present at the Canaccord Genuity 32nd Annual Growth Conference -- LAWRENCE, Mass., Aug. 10, 2012 /PRNewswire/ --

[ ]

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about NXTM

[ ]

[ Download image ]

LAWRENCE, Mass., Aug. 10, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: [ NXTM ]), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will present at the Canaccord Genuity 32^nd Annual Growth Conference on Tuesday, August 14th, at 4:30 p.m. ET.   A webcast of the event will be made available at [ http://ir.nxstage.com/ ] at the time of the presentation.  

(Logo:  [ http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ] )

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: [ NXTM ]) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at [ http://www.nxstage.com ].

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Mr. Burbank's plans to present at this conference.  NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.

Contact:
Kristen K. Sheppard, Esq.
Investor Relations
[ ksheppard@nxstage.com ]

SOURCE NxStage Medical, Inc.

RELATED LINKS
[ http://www.nxstage.com ]